scott galloway glp 1 Galloway: AI and GLP-1 medications have the potential to be transformative The biggest game-changing technology of
Description
[DOI] [PubMed] [Google Scholar] 89
M., Narva, A
Your GP or specialist can help weigh the potential metabolic benefits against any mental health considerations specific to your situation
demonstrated that GLP-1RAs are associated with significantly lower risks of pneumonia and severe sepsis in patients with type 2 diabetes compared to dipeptidyl peptidase-4 inhibitors (DPP-4is)
From personal experience, the majority of patients whom I manage their T2DM treatment on these medications have expressed issues obtaining their product
32 , 537547.e3 (2020)
